. Author manuscript; available in PMC: 2019 Jul 1.

Published in final edited form as: Clin Immunol. 2018 Mar 21;192:6–13. doi: 10.1016/j.clim.2018.03.010

Table 1.

Demographics By Trial Arm.

	EE	EE′	E′E	p-value
	N=10	N=10	N=10	p-value
Median Age (yrs)	53	60	52	0.26
Range	41–68	50–77	42–83
Breast	n=10	n=8	n=9
T Stage < T2	80.0%	62.5%	55.6%	0.59
Grade 3	40.0%	25.0%	44.4%	0.78
Node Positive	60.0%	37.5%	66.7%	0.56
Hormone Receptor+	60.0%	87.5%	55.6%	0.35
HER2+	30.0%	12.5%	11.1%	0.57
Ovarian	n=0	n=2	n=1